This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Suzhou Neologics Bioscience Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations of Baiyang Wang in Cancer Treatment
Introduction
Baiyang Wang is an accomplished inventor based in Princeton, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic antibodies.
Latest Patents
Wang holds a patent for TIM-3-targeting antibodies and their uses. This patent discloses anti-TIM-3 antibodies and antigen-binding fragments, along with polynucleotides encoding these antibodies and fragments. Additionally, it includes pharmaceutical compositions that comprise the antibodies and fragments. The patent also outlines the potential uses of these anti-TIM-3 antibodies in cancer treatment.
Career Highlights
Baiyang Wang is associated with Suzhou Neologics Bioscience Co., Ltd., where he continues to advance his research in the field of biotechnology. His work focuses on developing novel therapeutic strategies to combat cancer.
Collaborations
Wang collaborates with notable colleagues, including Xin Dong and Jinyu Dong, who contribute to his research efforts and innovations.
Conclusion
Baiyang Wang's work in developing TIM-3-targeting antibodies represents a significant advancement in cancer treatment. His innovative approach and dedication to research continue to pave the way for new therapeutic options in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile